Shed NAD+ is useful to examine because a commercial offer can answer one question while leaving another open. A displayed price tells us what the seller advertises; it does not tell us whether a finished preparation produces a meaningful health benefit. We follow those two threads separately in this review.
Our review uses public provider documents and primary scientific or regulatory references. We have not ordered Shed NAD+, sampled its contents or measured results in patients. Read the documented details below as a starting point for a more specific conversation, with the unknowns left visible rather than replaced by a score.
THE USEFUL DISTINCTION
Shed's shared NAD+ page begins at $144, but that figure belongs to nasal spray. The injection and oral-tablet cards each start at $169 per month. The oral offering appears within a prescribing service. It should not be silently classified as a retail supplement or judged using another brand's capsule trial.
The documented offer
Shed's shared NAD+ page begins at $144, but that figure belongs to nasal spray. The injection and oral-tablet cards each start at $169 per month.
The route cards describe a one-month supply without fully specifying every strength and package count. Ask for the actual dispensing details after clinical assessment.
The oral offering appears within a prescribing service. It should not be silently classified as a retail supplement or judged using another brand's capsule trial.
Read the offer at a glance
- Injection: From $169/month
- Nasal spray: From $144/month
- Oral tablets: From $169/month
- Supply: One month stated on each product card
These are the published terms for Shed NAD+ as checked on October 12, 2026. The graphic keeps the offer's own units and conditions; it is not a comparison of clinical effectiveness. A missing specification or fee has not been treated as zero.
The preparation changes the comparison
Shed is reviewed here as a provider, with the individual products linked below. A storefront can contain several routes, quantities and payment structures. A price on one product card should not be assigned to the entire catalog, and a service feature described for another treatment may not apply to the NAD+ or sermorelin offer. The final proposal should identify which product is under consideration and which organization performs assessment, dispensing or administration.
Evidence: Shed: injection, nasal and oral NAD+ offers / FDA: Compounding questions and answers / PubChem: Nicotinamide adenine dinucleotide / NIH Office of Dietary Supplements: Niacin
What would count as useful evidence
NAD+ participates in normal cellular metabolism. That fact explains scientific interest, but it does not establish that Shed NAD+ improves energy, cognition, recovery or longevity. Evidence from a different ingredient or route has to be identified as such. Where a compounded drug is offered, it is not FDA-approved; a pharmacy credential does not change the approval status of the finished preparation.
Look for a match between the research and the proposed product. The ingredient, route, studied population, comparison group and measured outcome all matter. For Shed NAD+, a change in a laboratory marker would answer a narrower question than improved everyday function. A story about feeling better cannot show what would have happened without treatment. Ask the clinician which finding actually supports the intended purpose and what remains uncertain.
Evidence: Shed: injection, nasal and oral NAD+ offers / FDA: Compounding questions and answers / PubChem: Nicotinamide adenine dinucleotide / NIH Office of Dietary Supplements: Niacin
Turn the unknowns into document requests
The next useful evidence is often ordinary paperwork. For Shed NAD+, obtain the exact order summary and, where relevant, the dispensing label, pharmacy identity and product-specific handling instructions. Compare what each document says rather than treating a prominent quality badge as an audit. An unresolved quantity or payment interval is a reason to seek clarification before calculating value.
For Shed NAD+, save the selected offer and confirm the amount due now, the next charge, and the cancellation point before a later order. If assessment does not lead to a prescription, ask which charges remain payable. If dispensing has already begun, the rules may differ. We have not completed checkout or independently verified refund handling, shipment quality or support speed.
Continue with the product and comparison questions
To keep Shed's different offers distinct, continue to Shed NAD+ Injection review; Shed NAD+ Nasal Spray review; Shed Oral NAD+ Tablets review. These pages separate provider-level questions from the preparation and purchase terms of each product. A provider review is not a substitute for reading the selected product agreement.
For the wider decision about Shed NAD+, use nad cost; nad safety; nad injections vs iv. Compare the complete commitment, relevant evidence and available professional support, rather than treating a lower headline or a more convenient route as a medical recommendation. CoreAge Rx's featured commercial position on this publication is disclosed separately and is not an effectiveness ranking.
Evidence: Shed: injection, nasal and oral NAD+ offers / FDA: Compounding questions and answers / PubChem: Nicotinamide adenine dinucleotide / NIH Office of Dietary Supplements: Niacin
Open the source material
- Shed: injection, nasal and oral NAD+ offers
Provider statement, not independent verification of outcomes. Offer checked October 12, 2026.
- FDA: Compounding questions and answers
Primary reference; does not endorse the reviewed provider.
- PubChem: Nicotinamide adenine dinucleotide
Primary reference; does not endorse the reviewed provider.
- NIH Office of Dietary Supplements: Niacin
Background on NAD and related nutrition; not a trial of this offer.
